Role of endothelin-1 and thromboxane A2 in renal vasoconstriction induced by angiotensin II in diabetes and hypertension

Kidney International, Supplement

Volumn 62, Issue 82, 2002, Pages S2-S7

  Cediel, Eva ^a   Vázquez Cruz, Beatriz ^a   Navarro Cid, Josefa ^a   De las Heras, Natalia ^a   Sanz Rosa, David ^a   Cachofeiro, Victoria ^a   Lahera, Vicente ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Arterial pressure; Chronic renal disease; Diabetes; Hypertension; Kidney; Renal vascular resistance

Indexed keywords

ANGIOTENSIN; ENDOTHELIN 1; ENDOTHELIN RECEPTOR ANTAGONIST; IFETROBAN; N ACETYL 10,11 DIHYDRO 5H DIBENZO[A,D]CYCLOHEPTEN 5 YLGLYCYLLEUCYLASPARTYLISOLEUCYLISOLEUCYLTRYPTOPHAN; THROMBOXANE A2; THROMBOXANE A2 RECEPTOR BLOCKING AGENT; ANGIOTENSIN II; ENDOTHELIN RECEPTOR; FUSED HETEROCYCLIC RINGS; OLIGOPEPTIDE; OXAZOLE DERIVATIVE; THROMBOXANE A2 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL PRESSURE; CONFERENCE PAPER; CONTROLLED STUDY; DIABETES MELLITUS; DRUG EFFECT; ESSENTIAL HYPERTENSION; GLUCOSE BLOOD LEVEL; ISOLATED ORGAN; KIDNEY BLOOD VESSEL; KIDNEY PERFUSION; MALE; MEDIATOR; NONHUMAN; PERFUSION PRESSURE; PRIORITY JOURNAL; RAT; RAT STRAIN; STREPTOZOCIN DIABETES; VASCULAR RESISTANCE; VASOCONSTRICTION; ANIMAL; ARTICLE; BLOOD PRESSURE; DOSE RESPONSE; DRUG ANTAGONISM; EXPERIMENTAL DIABETES MELLITUS; HYPERTENSION; KIDNEY; KIDNEY CIRCULATION; METABOLISM; PATHOPHYSIOLOGY; SPONTANEOUSLY HYPERTENSIVE RAT; VASCULARIZATION; WISTAR KYOTO RAT;

ANGIOTENSIN II; ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BLOOD PRESSURE; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIN-1; HYPERTENSION; KIDNEY; MALE; OLIGOPEPTIDES; OXAZOLES; RATS; RATS, INBRED SHR; RATS, INBRED WKY; RECEPTORS, ENDOTHELIN; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; RENAL CIRCULATION; THROMBOXANE A2; VASCULAR RESISTANCE; VASOCONSTRICTION;

EID: 0036433038     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.62.s82.2.x     Document Type: Article

References (38)

1. Parving HH: Hypertension and diabetes: The scope of the problem. Blood Press (Suppl 2):25-31, 2001
2. Ma L, Fogo AB: Role of angiotensin II in glomerular injury. Semin Nephrol 21:544-553, 2001
3. Unger T: The role of the renin-angiotensin system in the development of cardiovascular disease. Am J Cardiol 89:3-9, 2002
4. Nasjletti A, Arthur C: Corcoran Memorial Lecture. The role of eicosanoids in angiotensin-dependent hypertension. Hypertension 31:194-200, 1998
5. Wolf G, Ziyadeh FN: Molecular mechanisms of diabetic renal hypertrophy. Kidney Int 56:393-405, 1999
6. Schiffrin EL: Role of endothelin-1 in hypertension and vascular disease. Am J Hypertens 14(Suppl):83S-89S, 2001
7. Mistry M, Nasjletti A: Contrasting effect of thromboxane synthase inhibitors and a thromboxane receptor antagonist on the development of angiotensin II-salt-induced hypertension in rats. J Pharmacol Exp Ther 253:90-94, 1990
8. 2 inhibition on the renal hemodynamics in streptozotocin-induced diabetic rats. Kidney Int 45:794-802, 1994
9. A-receptor blockade in angiotensin II-induced hypertension. Hypertension 29:435-441, 1997
10. Chatziantoniou C, Daniels FH, Arendhorst WJ: Exaggerated renal vascular reactivity to angiotensin and thromboxane in young genetically hypertensive rats. Am J Physiol 259:F372-F382, 1990
11. Wilcox CS, Welch WJ: Thromboxane mediation of the pressor response to infused angiotensin II. Am J Hypertens 3:242-249, 1990
12. 2 analogue in aortic rings from spontaneously hypertensive rats: Role of nitric oxide. J Hypertens 12(Pt2):1677-1684, 1997
13. Maeso R, Rodrigo E, Muñoz-García R, et al: Chronic treatment with losartan ameliorates vascular dysfunction induced by aging in spontaneously hypertensive rats. J Hypertens 16:665-672, 1998
14. Cooper ME, Allen TJ, Jerums G, Doyle AE: Accelerated progression of diabetic nephropathy in the spontaneously hypertensive streptozotozin diabetic rat. Clin Exp Phramacol Physiol 13:655-661, 1986
15. Somani P, Singh HP, Saini RK, Rabinovitch A: Streptozotozin-induced diabetes in the spontaneously hypertensive rat. Metabolism 28:1075-1080, 1979
16. Yamamoto J: Blood pressure and metabolic effects of streptozotozin in Wistar Kyoto and spontaneously hypertensive rats. Clin Exp Hypertens 10:1065-1072, 1988
17. Beenen OHM, Mathy MJ, Pfaffendorf M, Van Zwieten PA: Vascular responsiveness in isolated perfused kidneys of diabetic hypertensive rats. J Hypertens 14:1125-1130, 1996
18. Farina NK, Hodgson WC, Widdop RE: Vascular reactivity to angiotensin II in blood-perfused kidneys of hypertensive diabetic rats. Eur J Pharmacol 310:185-191, 1996
19. Fink GD, Brody MJ: Renal vascular resistance and reactivity in the spontaneously hypertensive rat. Am J Physiol 237:F128-F132, 1979
20. Kost CK Jr, Kerzer WA, Li P, Jackson EK: Vascular reactivity to angiotensin II is selectively enhanced in the kidneys of spontaneously hypertensive rats. J Pharmacol Exp Ther 269:82-88, 1994
21. Awazu M, Parker RE, Harvie BR, et al: Down-regulation of endothelin-1 receptors by protein kinase C in streptozotocin diabetic rats. J Cardiovasc Pharmacol 17(Suppl 7):S500-S502, 1991
22. Vyas SJ, Jackson EK: Angiotensin II: Enhanced renal responsiveness in young genetically hypertensive rats. J Pharmacol Exp Ther 273:768-777, 1995
23. Inman SR, Porter JP, Fleming JT: Reduced renal microvascular reactivity to angiotensin II in diabetic rats. Microcirculation 1:137-145, 1994
24. Mayhan WG: Constrictor responses of the rat basilar artery during diabetes mellitus. Brain Res 783:326-331, 1998
25. Crijns FR, Struijker HA, Wolffenbuttel BH: Arteriolar reactivity in conscious diabetic rats: Influence of aminoguanidine treatment. Diabetes 47:918-923, 1998
26. 2) in isolated, perfused kidneys of spontaneously hypertensive rats. Biochem Pharmacol 28:3601-3609, 1979
27. Lin L, Nasjletti A: Role of endothelium-derived prostanoid in angiotensin-induced vasoconstriction. Hypertension 18:158-164, 1991
28. Dumont Y, D'Amours M, Lebel M, Lariviere R: Blood pressure-independent effect of angiotensin AT1 receptor blockade on renal endothelin-1 production in hypertensive uremic rats. J Hypertens 19:1479-1487, 2001
29. Boemke W, Hocher B, Schleyer N, et al: Hemodynamic, renal and endocrine responses to acute ET (A) blockade at different angiotensin II plasma levels. Am J Physiol 280:R1322-R1331, 2001
30. Ballew JR, Watts SW, Fink GD: Effects of salt intake and angiotensin II on vascular reactivity to endothelin-1. J Pharmacol Exp Ther 296:345-350, 2001
31. Dohi Y, Hahn AW, Boulanger CM, et al: Endothelin stimulated by angiotensin II augments contractility of spontaneously hypertensive rat resistance arteries. Hypertension 19:131-137, 1992
32. Ruan X, Arendhorst WJ: Role of protein kinase C in angiotensin II-induced renal vasoconstriction in genetically hypertensive rats. Am J Physiol 270(Pt 2):F945-F952, 1996
33. Wilcox CS, Welch WJ: Angiotensin II and thromboxane in the regulation of blood pressure and renal function. Kidney Int 38(Suppl 30):S81-S83, 1990
34. Cruz BV, Escalante B: Renal vascular interaction of angiotensin II and prostaglandins in renovascular hypertension. J Cardiovasc Pharmacol 34:21-27, 1999
35. 2 receptors in streptozotocin-induced diabetes: Effects of insulin therapy in the rat. Prostaglandins 45:427-38, 1993
36. Ficai S, Herizi A, Mimram A, Jover B: Endothelin blockade in angiotensin II hypertension: Prevention and treatment studies in the rat. Clin Exp Pharmacol Physiol 28:1100-1103, 2001
37. Tammesild PJ, Hodgson WC, King RG: Increased sensitivity to endothelin-1 in isolated Krebs'-perfused kidneys of streptozotocin-diabetic rats. Clin Exp Pharmacol Physiol 19:261-265, 1992
38. Hargrove GM, Dufresne J, Whiteside C, et al: Diabetes mellitus increases endothelin-1 gene transcription in rat kidney. Kidney Int 58:1534-1545, 2000